Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T S J Opstal

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Therapeutics|September 16, 2023
An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual RiskN Mohammadnia, T S J Opstal, S El Messaoudi, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 17, 2021
Targeting residual inflammatory risk in coronary disease: to catch a monkey by its tailA T L Fiolet, T S J Opstal, M J M Silvis, et al.
ESMO Gastrointestinal Oncology|April 22, 2026
Immune checkpoint inhibitor-induced myocarditis with atrioventricular conduction abnormalities: a case reportA Strijdhorst, T S J Opstal, L F H J Robbers, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Therapeutics|September 16, 2023
An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual RiskN Mohammadnia, T S J Opstal, S El Messaoudi, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 17, 2021
Targeting residual inflammatory risk in coronary disease: to catch a monkey by its tailA T L Fiolet, T S J Opstal, M J M Silvis, et al.
ESMO Gastrointestinal Oncology|April 22, 2026
Immune checkpoint inhibitor-induced myocarditis with atrioventricular conduction abnormalities: a case reportA Strijdhorst, T S J Opstal, L F H J Robbers, et al.
Pageof 1